Published in Ann Intern Med on September 01, 1982
Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol (1984) 14.64
The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 10.43
Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev (1987) 6.00
Methicillin-resistant staphylococci. Clin Microbiol Rev (1988) 3.77
In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother (1983) 3.00
The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ (2001) 2.99
Development of resistance in candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother (1991) 2.81
In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother (2002) 2.66
Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2006) 2.05
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1999) 1.92
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Stethoscopes as possible vectors of infection by staphylococci. BMJ (1993) 1.77
Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol (1983) 1.68
Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1989) 1.68
Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.63
Use of a primary isolation medium for recovery of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1992) 1.56
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J (2002) 1.43
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies. Antimicrob Agents Chemother (1986) 1.40
Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci U S A (2009) 1.37
Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods. J Clin Microbiol (1992) 1.33
Clinical and radiographic spectrum of septic pulmonary embolism. Arch Dis Child (2002) 1.25
Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples. J Clin Microbiol (2004) 1.24
Solonamide B inhibits quorum sensing and reduces Staphylococcus aureus mediated killing of human neutrophils. PLoS One (2014) 1.21
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.21
Community-acquired methicillin-resistant Staphylococcus aureus: prevalence and risk factors. J Athl Train (2006) 1.18
Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.18
Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1986) 1.17
Nontypeable bacteriophage patterns of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol (1989) 1.09
Nasal carriage of meticillin-resistant Staphylococcus aureus in GPs in the West of Ireland. Br J Gen Pract (2007) 1.09
Looking toward basic science for potential drug discovery targets against community-associated MRSA. Med Res Rev (2010) 1.08
Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India. Ann Clin Microbiol Antimicrob (2006) 1.07
In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.05
Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California. J Clin Microbiol (2007) 1.05
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Nurse Pract (2008) 1.04
Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother (1991) 1.03
Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect (2011) 1.03
Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004. Emerg Infect Dis (2008) 1.00
Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolates from Trinidad & Tobago. Ann Clin Microbiol Antimicrob (2006) 0.99
Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerg Infect Dis (2002) 0.98
Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrob Agents Chemother (2011) 0.97
Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr Infect Dis Rep (2003) 0.96
Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C. J Clin Microbiol (1984) 0.96
Transmission of methicillin-resistant Staphylococcus aureus in the long term care facilities in Hong Kong. BMC Infect Dis (2013) 0.95
Hand hygiene: back to the basics of infection control. Indian J Med Res (2011) 0.95
Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med (1984) 0.94
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA. PLoS One (2010) 0.94
Hand hygiene--the case for evidence-based education. J R Soc Med (2001) 0.94
Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother (2010) 0.91
Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia. Can J Infect Dis (2002) 0.89
Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus? J Antimicrob Chemother (2011) 0.89
Single-nucleotide polymorphism genotyping identifies a locally endemic clone of methicillin-resistant Staphylococcus aureus. PLoS One (2012) 0.88
Long-term persistence of MRSA in re-admitted patients. Infection (2010) 0.88
Staying one jump ahead of resistant Staphylococcus aureus. Br Med J (Clin Res Ed) (1986) 0.87
Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile. CMAJ (2009) 0.87
Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers. Antimicrob Agents Chemother (1987) 0.86
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. Can J Infect Dis (2004) 0.85
Pharmacokinetics of teicoplanin in pediatric patients. Antimicrob Agents Chemother (1988) 0.85
Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect (1988) 0.84
Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis (1998) 0.83
Methicillin-Resistant Staphylococcus aureus Infections. Curr Infect Dis Rep (1999) 0.82
Cotton textiles modified with citric acid as efficient anti-bacterial agent for prevention of nosocomial infections. Croat Med J (2011) 0.82
Photo-activated porphyrin in combination with antibiotics: therapies against Staphylococci. J Photochem Photobiol B (2013) 0.81
Methicillin-resistant Staphylococcus aureus: associated morbidity and effectiveness of control measures. Epidemiol Infect (1988) 0.80
Antibiotic sensitivity pattern of Staphylococcus aureus from clinical isolates in a tertiary health institution in Kano, Northwestern Nigeria. Pan Afr Med J (2011) 0.78
Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother (1990) 0.77
High prevalence of methicillin resistant staphylococci strains isolated from surgical site infections in Kinshasa. Pan Afr Med J (2014) 0.77
Eradication of methicillin-resistant Staphylococcus aureus from the lower respiratory tract of patients with cystic fibrosis. Can J Infect Dis (1995) 0.77
The general status of patients and limited physical activity as risk factors of Methicillin-resistant Staphylococcus aureus occurrence in long-term care facilities residents in Krakow, Poland. BMC Infect Dis (2014) 0.77
Impact of a surveillance screening program on rates of methicillin-resistant Staphylococcus aureus infections with a comparison of surgical versus nonsurgical patients. Proc (Bayl Univ Med Cent) (2014) 0.77
Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in New York health care facilities, 1988. The New York MRSA Study Group. Am J Public Health (1990) 0.76
Pro/con debate: are barrier precautions cost-effective in improving patient outcomes in the intensive care unit? Crit Care (2012) 0.76
Staphylococcal resistance to aminoglycosides before and after introduction of amikacin in two teaching hospitals. J Clin Microbiol (1986) 0.75
Nasal methicillin-resistant S. aureus is a major risk for mediastinitis in pediatric cardiac surgery. Ann Thorac Cardiovasc Surg (2015) 0.75
Knowledge, Attitude, and Practices of Healthcare Personnel Regarding the Transmission of Pathogens via Fomites at a Tertiary Care Hospital in Karachi, Pakistan. Open Forum Infect Dis (2015) 0.75
The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts. Bull N Y Acad Med (1984) 0.75
A descriptive survey of uncontrolled methicillin-resistant Staphylococcus aureus in a twin site general hospital. Postgrad Med J (1988) 0.75
Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis (1999) 10.30
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med (1988) 6.78
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis (1974) 6.38
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA (1994) 6.11
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med (1992) 5.28
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis (1995) 4.36
Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med (1989) 4.23
Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly-modified culture medium. J Infect Dis (1979) 4.15
Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med (1995) 3.75
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis (1998) 3.58
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med (1996) 3.53
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25
Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med (1991) 3.24
Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med (1980) 3.20
Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J (2000) 3.13
Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia. J Clin Microbiol (1985) 3.13
Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med (1989) 2.97
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis (1998) 2.94
Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol (1992) 2.90
Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med (1995) 2.86
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol (1990) 2.72
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1994) 2.67
Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis (1997) 2.67
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med (1992) 2.60
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
Contingency spaces and measures in classical and instrumental conditioning. J Exp Anal Behav (1974) 2.55
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology (1983) 2.32
The emergence of methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 2.32
ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J Virol (1994) 2.30
Long-term survival and function after suspected gram-negative sepsis. JAMA (1995) 2.27
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis (2000) 2.22
Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol (1994) 2.22
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology (1983) 2.19
The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol (1998) 2.18
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA (1993) 2.18
Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis (1981) 2.12
Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med (2000) 2.10
Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med (1993) 2.05
Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.05
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med (1998) 2.04
Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03
Smallpox vaccination for investigators using vaccinia recombinants. Lancet (1989) 2.00
Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis (1996) 1.99
Food-frequency questionnaires: a review of their design, validation and utilisation. Nutr Res Rev (2004) 1.99
Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control (1989) 1.98
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis (1997) 1.95
Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg (1977) 1.95
Characterization of the genes encoding herpes simplex virus type 1 and type 2 alkaline exonucleases and overlapping proteins. J Virol (1986) 1.92
Managing antibiotic resistance. N Engl J Med (2000) 1.90
Relation between surgical volume and incidence of postoperative wound infection. N Engl J Med (1981) 1.87
Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol (1986) 1.84
Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis (1987) 1.83
Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am J Epidemiol (1969) 1.82
Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis (1996) 1.78
Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital. Arch Intern Med (1986) 1.77
Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases. Am J Med (1984) 1.74
Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis (1997) 1.73
Anti-endotoxin monoclonal antibodies--a second look. N Engl J Med (1992) 1.73
Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.70
Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med (1987) 1.65
Infections related to central venous catheters. Mayo Clin Proc (1990) 1.64
Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J Virol (1992) 1.64
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. JAMA (1989) 1.59
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019. Diagn Microbiol Infect Dis (1988) 1.57
Emergence of coagulase negative staphylococci as major nosocomial bloodstream pathogens. Infect Control (1987) 1.57
Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis (1994) 1.56
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates. Eur J Clin Microbiol Infect Dis (1990) 1.56
Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol (1996) 1.55
An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J Virol (1995) 1.54
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J Clin Microbiol (1998) 1.53
The use of biotyping and DNA fingerprinting in typing Candida albicans from hospitalized patients. Diagn Microbiol Infect Dis (1991) 1.52
Removal of nosocomial pathogens from the contaminated glove. Implications for glove reuse and handwashing. Ann Intern Med (1988) 1.51
In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.51
Dietary antioxidants and asthma in adults: population-based case-control study. Am J Respir Crit Care Med (2001) 1.50
Oleoresin capsicum (pepper) spray and "in-custody deaths". Am J Forensic Med Pathol (1995) 1.49
Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol (1989) 1.48
Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer (1992) 1.47
Hospital-acquired infections. I. Surveillance in a university hospital. Am J Epidemiol (1976) 1.47
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3. J Clin Microbiol (1999) 1.44
Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroxime. J Thorac Cardiovasc Surg (1990) 1.44
Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J (2001) 1.44
Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol (1990) 1.44